These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1513076)

  • 1. Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
    Mori H; Sakamoto O; Kitaichi K; Koda A; Kita J
    Jpn J Pharmacol; 1992 Mar; 58(3):269-82. PubMed ID: 1513076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O; Mori H; Kitaichi K; Koda A; Kato T
    Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice.
    Mori H; Nakayama K; Maeda D; Nagai H; Koda A; Kita J; Kaku Y
    Cancer Chemother Pharmacol; 1994; 34(3):216-24. PubMed ID: 8004754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel low immunosuppressive derivatives of the antitumor drug fluoropyrimidine, UK-21 and UK-25: effect on delayed type hypersensitivity and tumor immunity.
    Sakamoto O; Mori H; Kitaichi K; Koda A
    Jpn J Pharmacol; 1993 Mar; 61(3):209-20. PubMed ID: 8483298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
    Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
    Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effect of new 5-fluorouracil derivatives and their influences on the immune response.
    Mori H; Nakatomi I; Kato Y; Koda A
    Jpn J Pharmacol; 1983 Dec; 33(6):1205-14. PubMed ID: 6668767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 5-fluorouridine and 5-fluorouracil in an experimental model for the treatment of vitreoretinal scarring.
    Ward T; Hartzer M; Blumenkranz M; Lin LR
    Curr Eye Res; 1993 May; 12(5):397-401. PubMed ID: 8344064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
    Yoshida M; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue.
    Kase S; Kubota T; Watanabe M; Teramoto T; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(3A):1155-9. PubMed ID: 8074466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
    Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
    Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil.
    Ohta Y; Sueki K; Kitta K; Takemoto K; Ishitsuka H; Yagi Y
    Gan; 1980 Apr; 71(2):190-6. PubMed ID: 6451468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.
    Itoh H; Ito H; Amano H; Noda H
    Jpn J Pharmacol; 1994 Oct; 66(2):265-71. PubMed ID: 7869611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M; Chiba Y; Okada S; Tamemasa O
    J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil derivative. XVII. Synthesis and antitumor activity of 5'-O-acyl-5-fluorouridines.
    Ozaki S; Akiyama T; Ike Y; Mori H; Hoshi A
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3405-8. PubMed ID: 2632088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
    Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
    Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of 1-acetyl-3-o-toluyl-5-fluorouracil against murine hepatoma MH134 and its effects on tissue weights following subcutaneous and oral administration.
    Yata N; Yamajo R; Okada T
    J Pharmacobiodyn; 1985 Apr; 8(4):264-9. PubMed ID: 4032217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil derivatives. XX. Synthesis and antitumor activity of 5'-O-unsaturated acyl-5-fluorouridines.
    Ozaki S; Akiyama T; Morita T; Kumegawa M; Nagase T; Uehara N; Hoshi A
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3164-6. PubMed ID: 2085902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.